糖化血清蛋白在预测下肢创伤性骨折病人近期预后中的价值

林志勇; 魏人前; 邓睿; 陈志城; 林志勇; 魏人前; 邓睿; 陈志城

doi:10.13898/j.cnki.issn.1000-2200.2018.02.023

[1]

FUKUSHIMA Y,DAIDA H,MORIMOTO T,et al.Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome:the Japan-ACS sub-study[J].Cardiovasc Diabetol,2013,4(12):5.

[2]

NUSA A,PATTI G,MARINO F,et al.Prognostic role of preprocedural glucose levels on short-and long-term outcome in patients undergoing percutaneous coronary revascularization[J].Catheter Cardiovasc Interv,2012,80(3):377.

[3]

刘丽丽.糖基化蛋白检测与糖尿病病人冠状动脉介入治疗围术期预后的关系[J].检验医学与临床,2014,11(1):15.

[4]

HARADA S,FUJITA-HAMABE W,TOKUYAMA S.Ischemic stroke and glucose intolerance:a review of the evidence and exploration ofnovel therapeutic targets[J].Pharmarol,2012,118(1):1.

[5]

刘海行,赵冬,王薇,等.血清高敏C反应蛋白水平与五年累积糖尿病发病风险的关系[J].中华流行病学杂志,2011,32(1):1.

[6]

GARCIA C,FEVE B,FERRE P,et al.Diabetes and inflammation:fundamental aspects and clinical implications[J].Diabet Metabol,2010,36(5):327.

[7]

李晓楠,刘军权.创伤性骨折病人血糖和糖化血清蛋白检测价值比较[J].检验医学,2015,30(2):152.

[8]

HERNANDEZ RK,DO TP,CRITCHLOW CW,et al.Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database[J].Acta Orthopaedica,2012,83(6):653.

[9]

NORRIS R,PARKER M.Diabetes mellitus and hip fracture:a study of 5966 cases[J].Injury,2011,42(11):1313.

[10]

赵海燕,王响,武丽芬,等.糖化血清蛋白试剂盒抗干扰能力的改进[J].检验医学,2010,25(3):247.

[11]

王婧,刘庆友,王东国.高水平糖化血红蛋白、糖化血清蛋白对急性脑梗死病人预后的影响[J].中国临床保健杂志,2014,17(2):184.

[12]

刘晓毅,杨林,祁光裕,等.白介素、c-反应蛋白和纤维蛋白原在下肢深静脉血栓炎症反应中的作用[J].中国普外基础与临床杂志,2010,17(7):660.

[13]

JEZOVNIK MK,POREDOS P.Idiopathic venous thrombosis is related tosystemic inflammatory response and to increasedlevels of circulating markel,3 of endothelial dysfunction[J].Int Angiol,2010,29(3):226.